By integrating evidence from cellular models, human atherosclerotic tissues, and genetically modified mice, we establish that the SENP3-KLF4 axis drives VSMCs transition towards a synthetic, pro-inflammatory phenotype and accelerates atherosclerosis development (Fig. 8). This evidence concerns the gene SENP3 and atherosclerosis.